Literature DB >> 10636408

Ocular optical aberrations after photorefractive keratectomy for myopia and myopic astigmatism.

T Seiler1, M Kaemmerer, P Mierdel, H E Krinke.   

Abstract

OBJECTIVES: To study the effects of photorefractive keratectomy on ocular optical aberrations and to establish correlations with glare vision and low-contrast vision.
METHODS: Preoperative ocular aberroscopy of 15 eyes undergoing photorefractive keratectomy was compared with aberroscopy at 3 months postoperatively by means of a newly developed automated aberroscope of the Tscherning type. The correlation of the wavefront errors with best spectacle-corrected visual acuity, low-contrast visual acuity, and visual acuity under glare conditions was analyzed.
RESULTS: In any individual treated, the total wavefront error increased. On average, the total wavefront error increased by a factor of 17.65; this increase was highly statistically significant (P = .001). Also, the correlation with best-corrected visual acuity, low-contrast visual acuity, and glare visual acuity was statistically significant (P = .02, P = .001, and P = .03, respectively). The increase in ocular aberrations was significantly related with the virtual pupil size.
CONCLUSIONS: Photorefractive keratectomy increases the ocular aberrations, impairing the visual performance of the eyes treated. In detail, scotopic visual measures such as low-contrast visual acuity and glare visual acuity suffer most from the myopia correction. Aberroscopy-guided photorefractive keratectomy may avoid such effects.

Entities:  

Mesh:

Year:  2000        PMID: 10636408     DOI: 10.1001/archopht.118.1.17

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  39 in total

1.  Clinical outcomes between optical path difference custom aspheric treatment and optimized prolate ablation photorefractive keratectomy in myopia exceeding 8 diopters.

Authors:  B J Choi; Y M Park; J S Lee
Journal:  Eye (Lond)       Date:  2014-11-14       Impact factor: 3.775

2.  The usefulness of Vistech and FACT contrast sensitivity charts for cataract and refractive surgery outcomes research.

Authors:  K Pesudovs; C A Hazel; R M L Doran; D B Elliott
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

Review 3.  [Current state of wavefront guided corneal surgery to correct refraction disorders].

Authors:  T Kohnen; J Bühren
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

4.  The effect of optical zone decentration on lower- and higher-order aberrations after photorefractive keratectomy in a cat model.

Authors:  Jens Bühren; Geunyoung Yoon; Shawn Kenner; Scott MacRae; Krystel Huxlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

Review 5.  [Application of wavefront analysis in clinical and scientific settings. From irregular astigmatism to aberrations of a higher order--Part II: examples].

Authors:  J Bühren; T Kohnen
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

6.  Photorefractive keratectomy in the cat eye: biological and optical outcomes.

Authors:  Lana J Nagy; Scott MacRae; Geunyoung Yoon; Matthew Wyble; Jianhua Wang; Ian Cox; Krystel R Huxlin
Journal:  J Cataract Refract Surg       Date:  2007-06       Impact factor: 3.351

Review 7.  [Ablation profiles in corneal laser surgery. Current and future concepts].

Authors:  M Mrochen; F Hafezi; M Jankov; T Seiler
Journal:  Ophthalmologe       Date:  2006-03       Impact factor: 1.059

8.  Effect of sampling on real ocular aberration measurements.

Authors:  Lourdes Llorente; Susana Marcos; Carlos Dorronsoro; Stephen A Burns
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-09       Impact factor: 2.129

9.  Higher-order aberrations and visual acuity after LASEK.

Authors:  Berrak Urgancioglu; Kamil Bilgihan; Sertac Ozturk
Journal:  Int Ophthalmol       Date:  2007-08-31       Impact factor: 2.031

10.  Optical effects of anti-TGFbeta treatment after photorefractive keratectomy in a cat model.

Authors:  Jens Bühren; Lana Nagy; Jennifer N Swanton; Shawn Kenner; Scott MacRae; Richard P Phipps; Krystel R Huxlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.